Tag: Biliary tract cancer
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract Cancer
China’s NMPA Accepts BLA for Zanidatamab in HER2+ Biliary Tract CancerThe National Medical Products Administration (NMPA) in China has approved the biologics license application...
BREAKING NEWS
Top Supreme Court Rulings of 2024: Presidential Immunity & Chevron Doctrine
Supreme Court Rulings of 2024: A Year of Legal LandmarksIn a year of tense legal battles and high-stakes decisions, the U.S. Supreme Court has...
